OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU research finds untreated obstructive sleep apnea nearly doubles Parkinson's disease risk, but early CPAP treatment improves outcomes.

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

The Lund Report covers OHSU research that finds corporate ownership of direct primary care and concierge medical clinics that charge a fee for a package of services has grown in the past five years from about 9% in 2018 to one-third in 2023. Jane Zhu, M.D., says, “DPC and concierge practices are often sold as sort of an alternative to the large corporate-owned practices that have been taking over the primary care landscape in recent years. And yet we're seeing that similar ownership structures are clearly taking hold in these alternative models of primary care."

OHSU-PSU School of Public Health research describes the potential impacts of delayed vaccination for hepatitis B in children. Eric Hall, Ph.D., says, “I don’t think many of us in the public health community thought six or eight months ago they would be looking at changing the infant hepatitis B vaccination schedule. This has been a great public health success. There has been no new evidence to arise that would indicate there’s any type of risk around hepatitis B vaccination for infants. With that in mind, I’m not entirely sure what’s next.”

The Portland Business Journal talks with Lisa Coussens, M.D., Shivaani Kummar, M.D., and Shannon McWeeney, Ph.D., about the challenges and opportunities impacting our state’s cancer research ecosystem and what is needed to maintain and accelerate the pace of innovation. “Health care in this country is facing obstacles like never before,” Coussens says. “The attack on biomedical research funding is unprecedented. We’re struggling to keep some of the most brilliant minds employed.”

STAT News covers a report from the Vaccine Integrity Project that urges against delaying the newborn dose of the hepatitis B vaccine, warning that postponing it could increase lifetime risk of chronic infection and liver disease. Eric Hall, Ph.D., says “The striking thing to me is this set of results indicates that even short delays in vaccination are substantially going to lead to more infections, more severe long-term health complications, and sharp increases in health care spending.”

Science News Explores reports that OHSU researchers have created human eggs from skin cells for the first time — though most of the lab-grown eggs showed chromosomal abnormalities and are not yet viable for reproduction. “It was not the outcome we wanted,” says Paula Amato, M.D. “But it was more proof-of-concept: ‘Hey, we can kind of make this process happen now.’”